Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Betulin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel semi-synthetic route for betulinic acid from betulin. High purity over 99 percent. Cost-effective industrial scale-up for pharmaceutical intermediates manufacturing.
Patent CN101759759B reveals a high-yield IBX and Bu4NMnO4 route for betulonic acid, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN104045680A details novel acetyl amino acid acyl derivatives of betulin with enhanced antitumor activity, offering scalable synthesis routes for pharmaceutical supply chains.
Advanced biocatalytic synthesis of betulinic acid using ionic liquids. Enhances yield and supply chain reliability for pharmaceutical intermediates.
Patent CN102226213B details enzymatic betulinic acid production. Offers safe, scalable pharmaceutical intermediate manufacturing with reduced environmental impact.